Hainan Huluwa Pharmaceutical Group Co., Ltd.

SHSE:605199 Stock Report

Market Cap: CN¥5.2b

Hainan Huluwa Pharmaceutical Group Management

Management criteria checks 2/4

Hainan Huluwa Pharmaceutical Group's CEO is Jinping Liu, appointed in Feb 2016, has a tenure of 8.75 years. directly owns 41.76% of the company’s shares, worth CN¥2.16B. The average tenure of the management team and the board of directors is 8.7 years and 6 years respectively.

Key information

Jinping Liu

Chief executive officer

CN¥1.4m

Total compensation

CEO salary percentagen/a
CEO tenure8.8yrs
CEO ownership41.8%
Management average tenure8.7yrs
Board average tenure6yrs

Recent management updates

Recent updates

We Think That There Are Issues Underlying Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Earnings

Nov 06
We Think That There Are Issues Underlying Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Earnings

Here's Why Hainan Huluwa Pharmaceutical Group (SHSE:605199) Has A Meaningful Debt Burden

Oct 23
Here's Why Hainan Huluwa Pharmaceutical Group (SHSE:605199) Has A Meaningful Debt Burden

Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) Shares Climb 27% But Its Business Is Yet to Catch Up

Sep 25
Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) Shares Climb 27% But Its Business Is Yet to Catch Up

There's Reason For Concern Over Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) Massive 27% Price Jump

Sep 25
There's Reason For Concern Over Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) Massive 27% Price Jump

Risks To Shareholder Returns Are Elevated At These Prices For Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199)

Jun 07
Risks To Shareholder Returns Are Elevated At These Prices For Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199)

Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Shareholders Have More To Worry About Than Only Soft Earnings

May 03
Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Shareholders Have More To Worry About Than Only Soft Earnings

CEO

Jinping Liu (54 yo)

8.8yrs

Tenure

CN¥1,406,000

Compensation

Ms. Liu Jinping serves as General Manager of Hainan Huluwa Pharmaceutical Group Co., Ltd. since February 26, 2016 and serves as its Chairman of the Board since December 2007 and serves as its Director.


Leadership Team

NamePositionTenureCompensationOwnership
Jinping Liu
GM & Chairman of the Board8.8yrsCN¥1.41m41.76%
CN¥ 2.2b
Qingtao Wang
Secretary3.4yrsCN¥517.80kno data
Tianbao Wei
Deputy General Manager8.7yrsCN¥435.70kno data
Wei Li
Accounting Supervisorno datano datano data

8.7yrs

Average Tenure

54yo

Average Age

Experienced Management: 605199's management team is seasoned and experienced (8.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jinping Liu
GM & Chairman of the Board16.9yrsCN¥1.41m41.76%
CN¥ 2.2b
Guihua Wang
Independent Director6yrsCN¥100.00kno data
Ping Liu
Supervisor6yrsno datano data
Peng Xu
Chairman of the Supervisory Boardno datano datano data

6.0yrs

Average Tenure

57.5yo

Average Age

Experienced Board: 605199's board of directors are considered experienced (6 years average tenure).